as 06-30-2025 12:33pm EST
uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases.
Founded: | 1998 | Country: | Netherlands |
Employees: | N/A | City: | AMSTERDAM |
Market Cap: | 725.4M | IPO Year: | 2007 |
Target Price: | $37.20 | AVG Volume (30 days): | 1.3M |
Analyst Decision: | Strong Buy | Number of Analysts: | 10 |
Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
EPS: | -4.37 | EPS Growth: | N/A |
52 Week Low/High: | $3.73 - $19.18 | Next Earning Date: | 07-31-2025 |
Revenue: | $20,201,000 | Revenue Growth: | 6.30% |
Revenue Growth (this year): | -21.83% | Revenue Growth (next year): | 278.91% |
Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
---|---|---|---|---|---|---|---|---|---|
POST LEONARD E | QURE | Director | Jun 20 '25 | Sell | $14.45 | 2,112 | $30,518.40 | 29,937 | |
Kaye Jack | QURE | Director | Jun 20 '25 | Sell | $14.45 | 2,112 | $30,518.40 | 20,439 | |
Meek David D. | QURE | Director | Jun 20 '25 | Sell | $14.45 | 2,112 | $30,518.40 | 34,190 | |
Gut Robert | QURE | Director | Jun 20 '25 | Sell | $14.45 | 3,336 | $48,205.20 | 56,879 | |
Springhorn Jeremy P. | QURE | Director | Jun 20 '25 | Sell | $14.45 | 2,112 | $30,518.40 | 37,694 | |
Balachandran Madhavan | QURE | Director | Jun 20 '25 | Sell | $14.45 | 2,112 | $30,518.40 | 37,697 | |
Potts Jeannette | QURE | Chief Legal Officer | Jun 16 '25 | Sell | $15.14 | 4,670 | $70,703.80 | 115,073 |
QURE Breaking Stock News: Dive into QURE Ticker-Specific Updates for Smart Investing
Insider Monkey
8 days ago
GlobeNewswire
20 days ago
TipRanks
a month ago
MT Newswires
a month ago
GlobeNewswire
a month ago
GlobeNewswire
a month ago
GlobeNewswire
a month ago
Zacks
2 months ago
The information presented on this page, "QURE uniQure N.V. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.